Deerland, Thione to Combine Antioxidants, Enzymes

Deerland Enzymes (Kennesaw, GA) is partnering with Thione International (Atlanta) to develop product applications combining Thione’s antioxidants technology with Deerland’s enzyme blends.

Thione is described as a healthcare technology company focusing on developing applications using a synergistic combination of antioxidants, enzymes, and minerals that replicate the body’s cellular antioxidant defense network.

Dr. Theodore Hersh, president and CEO of Thione, has been named chief science officer of the new venture. The companies say he will work closely with Hilton Dawson, Deerland’s chief technology officer, to lead product development.

“Our goal will be to develop enzyme and antioxidant compositions with significant clinical applications in order to ameliorate a person’s gastrointestinal symptoms, improve digestive function, and enhance nutrition,” said Hersh.

“As chairman/CEO of Thione International, Dr. Hersh’s own research and patented product launches will allow us to focus our new product development efforts in areas that include digestive health, antioxidants, inflammation, and recovery,” said Scott Ravech, CEO of Deerland Enzymes.

Hersh is a B.A. graduate from Harvard University and attended medical school at Columbia University, College of Physicians and Surgeons. He completed his postgraduate training in internal medicine and gastroenterology at Mt. Sinai Hospital in New York; The Mayo Clinic in Rochester, MN; and the Boston City Hospital, Harvard Division. He is a professor of medicine, emeritus, at Emory University School of Medicine in Atlanta. For 20 years, he was chairman of the university’s Institutional Review Board for Human Investigation.